Zinc Transporter ZnT1 mRNA Expression Is Negatively Associated with Leptin Serum Concentrations but Is not Associated with Insulin Resistance or Inflammatory Markers in Visceral Adipose Tissue
- PMID: 38319549
- DOI: 10.1007/s12011-024-04089-5
Zinc Transporter ZnT1 mRNA Expression Is Negatively Associated with Leptin Serum Concentrations but Is not Associated with Insulin Resistance or Inflammatory Markers in Visceral Adipose Tissue
Abstract
The aim of this study was to evaluate the relationship between biomarkers of chronic inflammation, insulin resistance, and zinc transporter ZnT1 expression in human visceral adipose tissue. Visceral adipose tissue obtained from 47 adults undergoing laparoscopic surgery for cholecystectomy was used to analyze ZnT1 mRNA expression by RT-qPCR. ZnT1 mRNA levels were compared between subjects with normal weight, overweight, and obesity. A significantly lower ZnT1 expression was observed in overweight and obesity compared with normal-weight subjects (p = 0.0016). Moreover, subjects with normal weight had significantly higher serum zinc concentration (97.7 ± 13.1 mg/L) than subjects with overweight (87.0 ± 12.8 mg/L) and obesity (83.1 ± 6.6 mg/L) (p = 0.002). Pearson test showed a positive correlation between serum zinc concentrations and ZnT1 mRNA expression in visceral adipose tissue (r = 0.323; p = 0.031) and a negative correlation with body mass index (r = - 0.358; p = 0.013). A linear regression model was used to analyze the associations between ZnT1 mRNA expression and serum zinc levels, insulin resistance (HOMA2-IR), serum adipokines (leptin and adiponectin), and serum inflammation biomarkers (tumor necrosis factor alpha, interleukin-6, and C-reactive protein). Interestingly, leptin concentrations were negatively associated with ZnT1 mRNA expression (p = 0.012); however, no significant associations were found for the rest of the analyzed variables. Future research is needed to analyze the causality of negative association between ZntT1 expression in visceral adipose tissue and leptin.
Keywords: Inflammation; Obesity; Zinc; Zinc transporters.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Low miR-222 expression in human visceral adipose tissue is associated with insulin resistance and PTEN and p53 mRNA levels.Endokrynol Pol. 2022;73(5):846-855. doi: 10.5603/EP.a2022.0057. Epub 2022 Aug 16. Endokrynol Pol. 2022. PMID: 35971931
-
Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome.Front Endocrinol (Lausanne). 2017 Mar 2;8:38. doi: 10.3389/fendo.2017.00038. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28303117 Free PMC article.
-
Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.Mol Cells. 2012 Jun;33(6):591-6. doi: 10.1007/s10059-012-0012-7. Epub 2012 Apr 27. Mol Cells. 2012. PMID: 22544171 Free PMC article.
-
The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity.Clin Endocrinol (Oxf). 2010 Mar;72(3):334-41. doi: 10.1111/j.1365-2265.2009.03658.x. Epub 2009 Jun 22. Clin Endocrinol (Oxf). 2010. PMID: 19549246
-
Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity.J Clin Endocrinol Metab. 1998 Mar;83(3):902-10. doi: 10.1210/jcem.83.3.4644. J Clin Endocrinol Metab. 1998. PMID: 9506746 Review.
References
-
- WHO Consultation on Obesity (1999: Ginebra, Suiza); y Organización Mundial de la Salud. (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. Organización Mundial de la Salud. https://apps.who.int/iris/handle/10665/42330 Accessed 21 June 2021.
-
- Scherer T, Lindtner C, Zielinski E, O’hare J, Filatova N, Buettner C (2012) Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J Biol Chem. https://doi.org/10.1074/jbc.M111.307348 - DOI - PubMed - PMC
-
- Shibata R, Ouchi N, Ohashi K, Murohara T (2017) The role of adipokines in cardiovascular disease. J Cardiol. https://doi.org/10.1016/j.jjcc.2017.02.006
-
- Calder PC, Albers R, Antoine JM (2009) Inflammatory disease processes and interactions with nutrition. Br J Nutr. https://doi.org/10.1017/S0007114509377867 - DOI - PubMed
-
- Troche C, Aydeir T, Cousins R (2016) Zinc transporter Slc39a14 regulates inflammatory signaling associated with hypertrophic adiposity. Am J Physiol Endocrinol Metab. https://doi.org/10.1152/ajpendo.00421.2015 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials